Explore Supplements Subscribe
The VerdictMODERATE CONVICTIONWorth-It: Situational ROI (58/100)

NAC is a real drug for a few real jobs — but the longevity pitch has zero outcome trial evidence.

Pick up your NAC bottle right now. Look at the dose. If it says 600 mg and you're taking it for "longevity," "anti-aging," or daily liver support — you're paying for a mechanism story that has zero human outcome trial evidence. The stuff works for narrow clinical jobs at specific doses; if your job isn't on the list, save the £15.

  1. NAC works for narrow jobs: it's the IV antidote for paracetamol overdose, it cuts COPD flare-ups at 1200 mg a day, it works as a psychiatric add-on for OCD and schizophrenia at 2400 mg a day or more.
  2. The dose people buy (600 mg) is sub-therapeutic for the psychiatric claims they bought it for, and the "longevity / glutathione boost" pitch has no human outcome trial behind it.
  3. If you're going to take it, match the dose to a real indication: 600 mg/day for COPD or male fertility (about one standard capsule), or 2400-3600 mg/day under a specialist for OCD/schizophrenia (four to six capsules split through the day).

NAC is short for N-acetylcysteine — the acetylated form of an amino acid your body uses to build glutathione, its main internal antioxidant. Think of glutathione like a fleet of cleanup vans inside your cells. Cysteine is the part the factory keeps running out of, so the fleet gets stuck waiting for parts. NAC delivers the part fast — the vans hit the road. That's why it saves lives in paracetamol overdose: the toxin burns through cleanup vans faster than the liver can build them, and IV NAC restocks the part overnight. The trick is that "more cleanup vans in the lab" hasn't translated to "you live longer" in any healthy-adult trial.

That's the general answer. Your stack is different.

Check your whole stack
SH
Dr. Seth Holbrook, DPT — Doctor of Physical Therapy • Coach to 300+ clients
I built The Verdict to cut through recycled health advice and show what the evidence actually supports.
Amino Acid Derivative · Antioxidant Precursor

NAC

N-Acetylcysteine: a real drug for a few real jobs — but the longevity pitch has zero outcome trial evidence.

Conditional

Pick up your NAC bottle and check the dose. If it says 600 mg and you're taking it for "longevity" or daily liver support, you're paying for a mechanism story with zero outcome trial behind it. The supplement only earns its money for narrow clinical jobs at specific doses.

Tonight, ask: do I have a real indication on the list — COPD with frequent flare-ups, OCD/schizophrenia under a specialist, or working with a fertility clinic? If yes, match the dose to the job. If no, save the £15 a month.

Takes 30 seconds. Saves £180 a year.

The Verdict

NAC is a real drug for a few real jobs — but the longevity pitch has zero outcome trial evidence.

NAC is short for N-acetylcysteine — a tweaked form of an amino acid your body uses to build glutathione, your cells' main internal antioxidant. Think of glutathione like a fleet of cleanup vans inside every cell. Cysteine is the part the factory keeps running short of, so vans sit idle waiting for parts. NAC delivers the part fast, the vans hit the road. That's why it saves lives in paracetamol overdose: the toxin burns through cleanup vans faster than the liver can build them, and IV NAC restocks the part overnight. The trick is — "more vans on the road in the lab" hasn't translated to "you live longer" in any healthy-adult trial.

  1. NAC works for narrow jobs. It's the IV antidote for paracetamol overdose, it cuts COPD flare-ups at 1200 mg a day, and it works as a psychiatric add-on for OCD and schizophrenia at 2400 mg a day or more.
  2. The dose people buy is wrong for what they bought it for. 600 mg/day is sub-therapeutic by four-to-six-fold for the psychiatric claims people most often buy it for, and the longevity / glutathione boost pitch has no human outcome trial behind it.
  3. If you're going to take it, match the dose to a real job. 600 mg/day for COPD or male fertility (one standard capsule), or 2400–3600 mg/day under a specialist for OCD/schizophrenia (four-to-six capsules split through the day).

Best for

COPD with chronic bronchitis or frequent flare-ups; OCD/schizophrenia/cannabis-dependence patients under specialist care; men with idiopathic infertility working with a fertility clinic.

Skip if

Healthy adult buying it for longevity, anti-aging, daily liver support or hangover protection; on nitroglycerin or anticoagulants without medical review; about to stack high-dose antioxidants around training sessions.

The protocol, then the safety, then the money

The Protocol

NAC dosing protocol

Match the dose to the indication. There is no single "general" dose — and 600 mg/day, the dose most consumer brands sell, is sub-therapeutic for the psychiatric claims people most often buy it for.

Population Dose Form / Timing Duration
COPD with chronic bronchitis 1200 mg/day (split 600 mg twice daily, about one capsule each) Oral capsule or effervescent, with meals ≥6 months
OCD adjunct (under psychiatric care, on SSRI) 2400–3000 mg/day (four-to-five capsules split 2–3×) Oral, with meals ≥12 weeks
Schizophrenia negative symptoms (antipsychotic adjunct) 2000–3600 mg/day split Oral, with meals ≥12 weeks
Cannabis dependence craving (adjunct) 1200–2400 mg/day split Oral ≥8 weeks
Idiopathic male infertility 600 mg/day (one capsule) Oral, daily 3–6 months with semen analysis follow-up
Paracetamol overdose (acute) IV 150 mg/kg load → 50 mg/kg over 4h → 100 mg/kg over 16h Hospital IV (Parvolex/Acetadote) — never self-administer Per protocol
Healthy adult prophylactic / longevity NO EVIDENCE-SUPPORTED DOSE — —

Forms — Standard Capsule Wins

Standard Oral Capsule
~4–10% systemic
The form used in over 90% of clinical trials for respiratory and psychiatric indications. Take with food to cut GI upset.
~£8–15/month at 1200 mg/day
Effervescent Tablet
Similar to capsule
Better tolerated if capsules cause stomach upset (Mucomyst, Fluimucil).
~£12–25/month
Liposomal / Sustained-Release
No comparative data
Marketing claim only. Zero head-to-head outcome evidence vs standard capsule. Don't pay the premium.
~£25–50/month

Absorption Tips

Take with food — GI upset is the dominant dose-limiting issue. Split daily total into 2–3 doses, especially above 1200 mg/day. The sulfur smell on breath and urine is normal and harmless — it just means the molecule is in your system. If you're buying in the US, prefer brands with USP, NSF, or ConsumerLab third-party testing — the FDA dispute over NAC's drug-vs-supplement status means label accuracy varies brand-to-brand.

Safety & Interactions

NAC safety profile

NAC's oral safety profile is excellent at trial doses up to 3600 mg/day — but the drug interactions are real, and a few are clinically meaningful. Get medical clearance before stacking with the items below.

Nitroglycerin / nitrates — Moderate

Potentiated vasodilation; hypotension risk. Avoid concurrent dosing without clinical review.

Active oncology chemotherapy — Moderate

Antioxidant activity may theoretically interfere with oxidative-stress chemo mechanisms. Oncologist consultation required before use.

Warfarin / DOACs — Low–Moderate

Theoretical antiplatelet potentiation; bleeding signal. Monitor INR; avoid stacking with other antiplatelets without review.

High-dose vitamin C/E around training — Low–Moderate

Stacking high-dose antioxidants pre/post training may blunt mitochondrial adaptation signalling. Don't combine if hypertrophy or endurance adaptation matters.

Avoid or Use Cautiously

Severe asthma with bronchospasm history: IV NAC can trigger bronchospasm; oral generally tolerated but proceed cautiously.
Pregnancy / lactation: IV use in obstetric paracetamol overdose is established; oral supplementation evidence limited — clinical guidance only.
Active bleeding diathesis or on multiple antiplatelets: Caution — additive antiplatelet activity.

Side Effects (Oral)

The dominant dose-limiting issue is GI upset (nausea, diarrhoea) — 3–10% at 1200 mg/day, higher above 2400 mg/day. Split dosing and taking with food fixes most of it. Sulfur-smelling breath and urine is common and harmless. Headache is mild and usually transient. Rash is under 1%; discontinue if it appears.

Upper Limit

No formal Tolerable Upper Intake Level — NAC is a drug, not a vitamin with EFSA UL. The highest dose tested chronically in RCTs is 3600 mg/day for 24 weeks (schizophrenia, OCD trials) with acceptable safety. Above 3600 mg/day, GI side effects climb and additional benefit evidence is thin.

Conviction

MODERATE

Per-endpoint stratified — paracetamol overdose IV: HIGH · COPD chronic bronchitis 1200 mg/day: HIGH · OCD adjunct 2400–3000 mg: MODERATE · schizophrenia negative symptoms 2000–3600 mg: MODERATE · cannabis dependence craving 1200–2400 mg: MODERATE · male idiopathic infertility 600 mg: MODERATE · inflammatory biomarkers: MODERATE · depression monotherapy: LOW · IPF monotherapy: DEBUNKED · contrast-induced nephropathy: DEBUNKED · healthy-adult longevity / anti-aging: LOW (no RCT evidence).

What would change this

A pre-registered RCT of ≥500 healthy 40–60-year-olds, NAC 1200 mg/day vs placebo for ≥24 months, with primary endpoints on validated aging biomarkers (epigenetic age, inflammatory panels, frailty index) and clinically meaningful effect sizes — would upgrade the healthy-adult longevity claim from LOW to MODERATE. A pre-registered RCT of ≥300 depression patients, NAC 2400–3600 mg/day × 12 weeks vs placebo, primary endpoint HAM-D/MADRS with effect size ≥0.3 SD plus independent replication — would upgrade depression monotherapy from LOW to MODERATE-HIGH.

Worth Your Money?

Weekly cost~£2–4/week at 1200 mg/day (one capsule twice daily). ~£6–15/week at psychiatric adjunct doses (2400–3600 mg/day, four-to-six capsules split). IV use is hospital-only.
Worth it ifYou have a real indication on the list — COPD with frequent flare-ups, OCD or schizophrenia under specialist care, cannabis dependence in treatment, or you're working with a fertility clinic on idiopathic male infertility.
Lower priority ifYou're a healthy adult buying it for "longevity," "anti-aging," "glutathione boost," or daily liver support. Your next £15 a month is likely better spent on adequate protein, sleep setup, or third-party-tested whey — all of which feed your glutathione precursor pool from food and have outcome evidence the consumer NAC pitch lacks.
Conditional Value

Go Deeper

Want to stop wasting money on supplements that don't work? The Verdict reviews one every week — free.

Join The Verdict
Claims vs Evidence — See What the Research Found

What People Claim

NAC marketing claims

NAC is sold as a glutathione-precursor longevity supplement. The marketing story: cysteine is the rate-limiting amino acid for glutathione synthesis, glutathione is the body's master antioxidant, oxidative stress drives aging, therefore NAC is anti-aging. Influencer protocols typically recommend 600–1200 mg/day for general "detox," liver support, and immune resilience.

A second cluster targets liver protection — particularly hangover prevention or daily liver maintenance for drinkers. This is a downstream extrapolation from NAC's well-established role as the IV antidote for paracetamol overdose.

A third cluster targets respiratory health (mucolytic, "lung detox") and male fertility. The respiratory story is grounded in real clinical use; the fertility story has emerging trial support; the daily liver-support story has essentially no human outcome evidence at consumer doses outside of acute overdose contexts.

What the Evidence Actually Shows

NAC evidence map
Claimed BenefitEvidenceEffect SizeVerdict
Paracetamol overdose mortality (IV)STRONGLarge mortality + hepatic failure reductionWorks (clinical)
COPD exacerbation reduction (1200 mg/day, chronic bronchitis)STRONGSignificant exacerbation reduction; minimal at 600 mg/dayWorks
OCD symptom reduction (SSRI adjunct, 2400–3000 mg)MODERATESmall-to-moderate Y-BOCS reductionWorks (adjunct, dose-specific)
Schizophrenia negative symptoms (antipsychotic adjunct, 2000–3600 mg)MODERATESignificant PANSS total + negative symptom reductionWorks (adjunct, dose-specific)
Cannabis dependence craving (1200–2400 mg)MODERATEReduced craving + useWorks (adjunct)
Idiopathic male infertility (600 mg, 3–6 mo)MODERATEImproved sperm concentration, motility, morphologyWorks
Inflammatory biomarkers (CRP, IL-6, TNF-α)MODERATEModerate biomarker reductionWorks (biomarker level)
Autism spectrum (irritability, repetitive behaviour)MODERATESmall-to-moderate behavioural improvementWorks (modest, adjunct)
Depression monotherapyLOWModest, mixedUnproven as standalone
Athletic performance enhancementLOWMixed; high-dose may blunt adaptationUnproven; possible harm to training adaptation
IPF disease progression (monotherapy)DEBUNKEDNetwork metas show no benefit; PANTHER-IPF combo arm halted for HARMDon't use
Contrast-induced nephropathy preventionDEBUNKEDUpdated reviews mostly null/inconsistentDon't use
Healthy-adult longevity / anti-agingLOWGlutathione elevation documented; zero outcome RCTs in healthy adultsUnproven
Hangover / casual liver supportLOWNo RCT at consumer doses outside overdose contextUnproven
The Full Picture — Mechanism, Debate & Nuance

How It Works

NAC mechanism of action

NAC is the N-acetylated form of the amino acid cysteine. The acetyl group makes it more stable and absorbable than plain cysteine. Once inside cells, it does three things at once.

First and most important: it provides cysteine, the rate-limiting building block for glutathione synthesis. In a paracetamol overdose, the toxic metabolite NAPQI burns through hepatic glutathione faster than the liver can rebuild it; IV NAC dumps cysteine into hepatocytes fast enough to restore the antioxidant pool and prevent liver failure. This is the lifesaving mechanism and the foundation for every other claim.

Second, NAC carries a free sulfhydryl (–SH) group that physically cleaves the disulfide bonds holding mucus glycoprotein chains together. That is the mucolytic mechanism — it makes mucus thinner. This is the foundation for COPD and chronic bronchitis use.

Third, NAC has direct antioxidant + anti-inflammatory effects: it scavenges some free radicals on its own (less potent than glutathione but additive) and modulates the NF-κB inflammatory signalling pathway. This is the broad mechanism underneath the inflammation, psychiatric, and male fertility literature — but mechanism-level activity does not always translate to outcome benefit at every dose and population.

The Debate

IPF — works vs harms

Pre-2014 metas
Suggested NAC reduces IPF disease progression. Early enthusiasm based on mechanism + small trials.
VS
PANTHER-IPF 2014 + Fowdar 2017; Rogliani 2020
PANTHER-IPF combo arm (NAC + prednisone + azathioprine) halted for HARM. Subsequent network metas: NAC monotherapy not effective for IPF.

Evidence has matured negatively. Current consensus: NAC is not standard IPF treatment.

Dose-response for psychiatric use

Yolland 2020 meta (6 RCTs)
Schizophrenia PANSS reduction at 2000+ mg/day × 12+ weeks adjunct to antipsychotic.
VS
Earlier 1200 mg/day trials
Often null or mixed.

Dose + duration. Effect requires ≥2000 mg/day for ≥12 weeks. Lower doses or shorter trials are underpowered.

Athletes — performance vs adaptation blunting

Cotgreave 2017 meta
NAC modestly improves some performance markers acutely.
VS
High-dose post-exercise antioxidant literature
High-dose vitamin C/E + NAC stacks post-training may blunt mitochondrial adaptation signalling.

Timing + intent matter. Acute pre-exercise NAC may aid performance; chronic high-dose post-exercise stacking is a real adaptation concern.

Honest Limitations

Dose-response asymmetry

Trials use indication-specific doses (600 mg for COPD/fertility, 2400–3600 mg for psychiatric). Reality: consumers buy 600 mg capsules and assume one dose covers all the marketed claims. Outcome: the consumer dose is often four-to-six-fold too low for the psychiatric claims people are buying it for, and the longevity claim has no validated dose at all.

Regulatory product quality variance

Trials use pharmaceutical-grade NAC. The US consumer market sits in a regulatory gray zone after FDA 2020–2022 warning letters; "NAC 600 mg" can mean 300–900 mg actual content brand-to-brand. Third-party testing (USP, NSF, ConsumerLab) is the only meaningful quality floor — without it, you may be taking a different dose than you think.

Mechanism-to-outcome gap on longevity

Trials confirm NAC raises plasma glutathione. They do not show — at any dose, in any healthy-adult population — that this translates to lower mortality, slower epigenetic aging, or reduced frailty. Consumers buying NAC for longevity are paying for the mechanism story, not for trial evidence.

The Nuance

NAC population stratification

NAC is the textbook example of a supplement where evidence is real and narrow at the same time. Match the dose to the indication, ignore the umbrella longevity pitch, and don't pay premium prices for "liposomal" or "sustained-release" versions that have no head-to-head outcome data.

What doesn't work

  • NAC for healthy-adult longevity / anti-aging. Glutathione rises; aging biomarkers, mortality, frailty don't. Mechanism story isn't outcome evidence.
  • NAC monotherapy for IPF. Network metas updated post-PANTHER show no benefit; combination arm caused harm.
  • NAC for contrast-induced nephropathy prevention. Most current critical care reviews show null/inconsistent results.
  • NAC at 600 mg/day for psychiatric indications. Sub-therapeutic by 4–6×. Trials require 2000+ mg/day.
  • Premium "liposomal" or "sustained-release" NAC over standard capsule. No head-to-head clinical outcome evidence justifies the markup.
  • NAC as standard cardioprotection for chemotherapy. Cochrane review: mixed evidence; not a standard intervention.
  • Brand claims that "Brand X NAC raises glutathione 50% more than Brand Y." No comparative pharmacokinetic RCTs exist.

Food alternatives

Dietary cysteine — eggs, whey protein, poultry, garlic, onions — feeds the same glutathione precursor pool but doesn't replicate NAC's specific pharmacology (bypassing first-pass metabolism in IV use, mucolytic disulfide-cleaving). For "I want to keep my glutathione precursor pool topped up" at a consumer level, food works fine. For the specific clinical jobs NAC is dosed for in trials, food doesn't substitute.

Sources

  1. Chowdhury A, et al. (2018). Interventions for paracetamol (acetaminophen) overdose. Cochrane Database Syst Rev. PMID 29473717. IV NAC gold-standard antidote.
  2. Cazzola M, et al. (2017). Impact of Mucolytic Agents on COPD Exacerbations: A Pair-wise and Network Meta-analysis. Eur Respir J. PMID 28753070. NAC reduces COPD exacerbations.
  3. Fowdar K, et al. (2017). Efficacy of N-Acetylcysteine in Idiopathic Pulmonary Fibrosis: A Systematic Review and Meta-Analysis. Pulm Pharmacol Ther. PMID 27175674. IPF monotherapy modest; combination harm signal.
  4. Zheng Y, et al. (2023). The efficacy of N-acetylcysteine in chronic obstructive pulmonary disease patients: a meta-analysis. Respir Res. PMID 36927162. COPD FEV1 + exacerbation benefits.
  5. Yolland CO, et al. (2020). Meta-analysis of randomised controlled trials with N-acetylcysteine in the treatment of schizophrenia. Aust N Z J Psychiatry. PMID 31826654. Schizophrenia PANSS reduction (6 RCTs).
  6. Cooney R, et al. (2018). N-acetylcysteine for major mental disorders: a systematic review and meta-analysis of randomized controlled trials. Psychiatry Res. PMID 29457216. Multi-psychiatric meta.
  7. Pushpakom SP, et al. (2019). Pharmacotherapies for cannabis dependence. Cochrane Database Syst Rev. PMID 30687936.
  8. Shahmir H, et al. (2021). The role of N-acetyl-cysteine on sperm parameters and serum hormones in idiopathic infertile males. Andrologia. PMID 33405232. Male fertility meta.
  9. Faghfouri AH, et al. (2020). The effects of N-acetylcysteine on inflammatory and oxidative stress biomarkers: A systematic review and meta-analysis of controlled clinical trials. Eur J Pharmacol. PMID 32726657.
  10. Cotgreave IA, et al. (2017). Performance and Side Effects of Supplementation with N-Acetylcysteine: A Systematic Review and Meta-Analysis. Sports Med. PMID 28102488.

Action ROI

Is this worth your time, money, effort, risk, and trust for this goal? Different from Verdict Score (evidence strength) and Leverage Map (relative importance) — Action ROI is the worth-it call once friction is priced in.

Action ROI score
58/100 Situational ROI Trust grade C
Conditional - real if you have COPD or a specific clinical reason at the right dose, no for general antioxidant, liver, or detox support.
Time
Low
Money
Low
Effort
Low
Risk
Medium
Why this score
Why it didn’t score higher
Best for
Lower ROI if
Minimum effective dose
Dose to the indication, do not average: 1200 mg/day split for COPD, 2400 to 3600 mg/day split for psychiatric adjunct under a specialist, 600 mg/day for male fertility. Take with food. For general 'health' or 'detox' there is no evidence-supported dose.
Track this

Get the complete dosing protocol

Evidence-scored dosing, timing, forms, and who should skip it. One page, no fluff.

Get the protocol

Related free research

Supplements
Plant Sterols & Stanols — The Verdict
 Supplements
Exogenous Ketones — The Verdict
 Supplements
Serrapeptase — Does the Silkworm Enzyme Actually Work?

There are 424 more inside

Conviction-scored verdicts on supplements, nutrition, training, physio, and recovery.

Explore all Get weekly verdicts